www.fdanews.com/articles/143049-study-counters-fda-rsquo-s-decision-to-warn-for-blockbuster-plavix
Study Counters FDA’s Decision to Warn for Blockbuster Plavix
January 9, 2012
A boxed warning recommending patients receive a genetic test before taking blockbuster blood-thinner Plavix may be unnecessary, according to a review of 32 studies of the drug.
Washington Drug Letter
Washington Drug Letter